ETHYL 7-BROMO-3-(3-HYDROXYPROPYL)-1H-INDOLE-2-CARBOXYLATE, 95.0%, 1g

2-(Propan-2-yloxy)pyridine-3-carboxylic acid, 1g

7-(4-Methoxy-phenyl)-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid, 50mg

Ethyl 2-(5-aminopyridin-2-yl)acetate, 95.0%, 5g

2-Propanol, min 99,5 %, pour la synthèse, 25 l, avec bl.

Midecamycin, >98.0%, 1g

4-Bromo-2-fluorobenzylamine hydrochloride, 98.0%, 5g

1-Bromo-3,5-dinitrobenzene, 95.0%, 1g

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate, 95.0%, 25g

Methyl 3-amino-4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate, 97%, 1g

4-Chloro-2-(trifluoromethyl)quinazoline, 98.0%, 250mg

N-[6-(1-HYDROXY-1-METHYL-ETHYL)-2-(2-METHYLSULFONYLETHYL)INDAZOL-5-YL]-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE, 95%, 250mg

2-Fluoro-6-[(tetrahydrofuran-2-yl)methoxy]aniline, 95.0%, 1g